FDA Request For Clarifying DSHEA, Like Mandatory Listing, Splits US Supplement Industry Groups

 
• By Malcolm Spicer

Already differing on supporting FDA suggestion for mandatory annual registration of each VMS product sold in US, consumer health industry stakeholders’ schism now extends to agency suggestion that Congress clarify its regulatory authority over supplement manufacturing and marketing.

• Source: Alamy

The consumer health products industry hasn’t been unanimous about agreeing with the Food and Drug Administration on imposing mandatory annual registration of each dietary supplement product sold in the US.

The schism also now extends to the agency’s suggestion to Congress included in the justification document for its fiscal year 2023 budget request to clarify its regulatory authority over

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation